Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Rifamycin SV After Sapphire FUE
NCT07155408Completed
- Start
- Dec 2021
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of rifamycin SV-MMX in wound healing (2 arms). Primary endpoint: Recorded Early Healing Category. Started Dec 2021; status: completed.
02
Drugs
rifamycin SV-MMX
03
Conditions
wound healing
Beyond the preview
Go deeper on NCT07155408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07155408.